Principal Scientist
Merck & Co., Inc.
Disclosure(s): Merck & Co., Inc.: Full time employee, Stocks/Bonds (Public Company)
Dr. Oluwaseun Sharomi is a Principal Scientist and Health Economist at Merck, where he has led modeling activities for Rotavirus and is currently leading and supporting modeling activities for Epstein-Barr Virus and Pneumococcal Disease. Prior to joining Merck, Dr. Sharomi served as an Associate Director of Modeling at CHEORS and as an Assistant Professor in the Department of Mathematics at Khalifa University in the United Arab Emirates.
Dr. Sharomi’s work focuses on using mathematical modeling approaches and analysis to understand the transmission dynamics and control of emerging and re-emerging diseases of public health interest. He has designed, analyzed, and simulated novel mathematical models for the spread of various diseases, including respiratory diseases (H1N1, Mycobacterium tuberculosis), sexually transmitted infections (Chlamydia, HIV, HPV, syphilis), and their coinfections (e.g., HIV-TB coinfection). Dr. Sharomi has used these models to provide realistic assessments of various intervention strategies, such as vaccines (e.g., for H1N1 and HPV) and drug treatments (e.g., for HIV).
His statistical skills include proficiency in parameter estimation, uncertainty and sensitivity analysis of model parameters, optimal control analysis, and fitting models to data. Dr. Sharomi’s expertise also encompasses the design and analysis of mathematical models of infectious diseases, simulation of electrical activity in myocardial tissue, parallel computing, problem-solving environments, and numerical algorithms and software for exascale computer architectures.